ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

FREQ Company Profile and Key Details

NASDAQ : FREQ

Frequency Therapeutics, Inc.

$0.30

0.0136+4.76%

At Close 4:00 PM

Not Actively Trading

66.51

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Frequency Therapeutics, Inc. (FREQ) stock surged +4.76%, trading at $0.30 on NASDAQ, up from the previous close of $0.29. The stock opened at $0.29, fluctuating between $0.28 and $0.32 in the recent session.

Stock Snapshot

0.286

Prev. Close

0.29

Open

10.94M

Market Cap

36.52M

Number of Shares

0.28

Day Low

0.32

Day High

-0.1576842105263158

P/E Ratio

96.73%

Free Float in %

-1.9

EPS (TTM)

0.99

Book Value

-1.03

Cash Flow per Share

309.16K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Nov 03, 2023	0.29	0.32	0.28	0.30	309.16K
Nov 02, 2023	0.25	0.29	0.23	0.28	158.73K
Nov 01, 2023	0.25	0.26	0.24	0.25	104.28K
Oct 31, 2023	0.20	0.26	0.20	0.24	197.55K
Oct 30, 2023	0.22	0.23	0.18	0.22	536.94K
Oct 27, 2023	0.25	0.27	0.23	0.23	136.38K
Oct 26, 2023	0.23	0.25	0.23	0.24	65.18K
Oct 25, 2023	0.27	0.27	0.22	0.24	101.14K
Oct 24, 2023	0.25	0.28	0.24	0.26	79.07K
Oct 23, 2023	0.25	0.28	0.24	0.25	180.78K
Oct 20, 2023	0.24	0.27	0.24	0.25	43.28K
Oct 19, 2023	0.27	0.28	0.23	0.24	340.31K
Oct 18, 2023	0.30	0.30	0.27	0.27	94.43K
Oct 17, 2023	0.30	0.33	0.28	0.29	187.62K
Oct 16, 2023	0.29	0.33	0.29	0.30	80.47K
Oct 13, 2023	0.32	0.34	0.29	0.30	37.18K
Oct 12, 2023	0.34	0.34	0.28	0.28	108.6K
Oct 11, 2023	0.30	0.35	0.29	0.31	56.83K
Oct 10, 2023	0.29	0.32	0.28	0.30	46.69K
Oct 09, 2023	0.31	0.35	0.29	0.30	154.18K

Contact Details

Lexington, MA 02421

United States

Website: https://www.frequencytx.comContact: 781 315 4600

About Company

Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIa clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. The company has a license and collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322, as well as collaboration and licensing agreements with Massachusetts Eye and Ear, the Massachusetts Institute of Technology, The Scripps Research Institute, and Cambridge Enterprises Limited. Frequency Therapeutics, Inc. was incorporated in 2014 and is headquartered in Lexington, Massachusetts.

Frequently Asked Questions

What is the current Frequency Therapeutics, Inc. (FREQ) stock price?

Frequency Therapeutics, Inc. (NASDAQ: FREQ) stock price is $0.30 in the last trading session. During the trading session, FREQ stock reached the peak price of $0.32 while $0.28 was the lowest point it dropped to. The percentage change in FREQ stock occurred in the recent session was 4.76% while the dollar amount for the price change in FREQ stock was $0.01.

FREQ's industry and sector of operation?

The NASDAQ listed FREQ is part of Biotechnology industry that operates in the broader Healthcare sector. Frequency Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of FREQ?

Ms. Wendy S. Arnold
Chief People Officer
Mr. Jason Glashow
Senior Vice President of Corporation Affairs
Dr. William W. Chin M.D.
Senior Vice President of Translational Medicine
Mr. James P. Abely
Associate Gen. Counsel & Sec.
Dr. Christopher R. Loose Ph.D.
Co-Founder & Chief Scientific Officer
Mr. Richard J. Mitrano
Vice President of Fin. & Operations
Dr. Dana C. Hilt M.D.
Chief Medical Officer (acting)
Mr. David L. Lucchino
Co-Founder, Pres, Chief Executive Officer & Director
Dr. John L. LaMattina Ph.D.
Senior Advisor & Member of PCA Regenerative Medicine Advisory Board
Dr. Carl P. LeBel Ph.D.
Chief Devel. Officer
Dr. Lisa Geller J.D., Ph.D.
Senior Vice President of Intellectual Property
Dr. Quentin McCubbin Ph.D.
Chief Manufacturing Officer

How FREQ did perform over past 52-week?

FREQ's closing price is 63.72% higher than its 52-week low of $0.18 where as its distance from 52-week high of $5.59 is -94.64%.

How many employees does FREQ have?

Number of FREQ employees currently stands at 46.

Link for FREQ official website?

Official Website of FREQ is: https://www.frequencytx.com

How do I contact FREQ?

FREQ could be contacted at phone 781 315 4600 and can also be accessed through its website. FREQ operates from 75 Hayden Avenue, Lexington, MA 02421, United States.

How many shares of FREQ are traded daily?

FREQ stock volume for the day was 309.16K shares. The average number of FREQ shares traded daily for last 3 months was 135.08K.

What is the market cap of FREQ currently?

The market value of FREQ currently stands at $10.94M with its latest stock price at $0.30 and 36.52M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

News

Investing Crypto Market Business US Stocks

Useful Links

Screener Market Data Insider Transactions Upgrades & Downgrades 52 Week Highs & Lows Unusual Volume Dividend Calendar Earnings Calendar

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	46
Beta	0.77
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology